IRIS
PASSINO, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 49.287
EU - Europa 30.372
AS - Asia 24.567
SA - Sud America 5.370
AF - Africa 654
OC - Oceania 138
Continente sconosciuto - Info sul continente non disponibili 109
Totale 110.497
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 46.588
SG - Singapore 9.463
GB - Regno Unito 7.235
RU - Federazione Russa 7.235
CN - Cina 6.314
IT - Italia 4.794
BR - Brasile 4.195
VN - Vietnam 3.628
UA - Ucraina 2.331
DE - Germania 2.301
CA - Canada 2.076
HK - Hong Kong 1.933
DK - Danimarca 1.529
FR - Francia 1.112
FI - Finlandia 840
SE - Svezia 819
IN - India 556
IE - Irlanda 549
PL - Polonia 533
MX - Messico 458
AR - Argentina 433
BD - Bangladesh 379
NL - Olanda 362
TR - Turchia 324
IL - Israele 279
ID - Indonesia 241
EC - Ecuador 214
IQ - Iraq 214
ZA - Sudafrica 211
PK - Pakistan 203
JP - Giappone 198
ES - Italia 182
CO - Colombia 137
AT - Austria 114
VE - Venezuela 111
EU - Europa 106
AU - Australia 103
UZ - Uzbekistan 100
MA - Marocco 98
SA - Arabia Saudita 90
CL - Cile 85
KR - Corea 73
PY - Paraguay 67
IR - Iran 65
AE - Emirati Arabi Uniti 64
KE - Kenya 64
EG - Egitto 60
PH - Filippine 60
LT - Lituania 58
PE - Perù 55
TN - Tunisia 52
MY - Malesia 50
RO - Romania 48
JO - Giordania 46
DZ - Algeria 41
BE - Belgio 37
CH - Svizzera 35
BO - Bolivia 33
UY - Uruguay 33
NZ - Nuova Zelanda 32
AZ - Azerbaigian 31
CZ - Repubblica Ceca 30
ET - Etiopia 30
NP - Nepal 30
SK - Slovacchia (Repubblica Slovacca) 30
TH - Thailandia 30
CR - Costa Rica 27
PT - Portogallo 27
KZ - Kazakistan 23
JM - Giamaica 22
TW - Taiwan 22
HN - Honduras 21
GR - Grecia 20
DO - Repubblica Dominicana 19
KG - Kirghizistan 18
PS - Palestinian Territory 17
AL - Albania 16
OM - Oman 16
HU - Ungheria 15
PA - Panama 15
QA - Qatar 15
TT - Trinidad e Tobago 15
NI - Nicaragua 14
GE - Georgia 13
AM - Armenia 12
LV - Lettonia 12
RS - Serbia 12
BY - Bielorussia 11
NO - Norvegia 11
SN - Senegal 11
BG - Bulgaria 10
BH - Bahrain 10
CI - Costa d'Avorio 10
KW - Kuwait 10
LB - Libano 10
MK - Macedonia 10
HR - Croazia 9
SI - Slovenia 9
AO - Angola 8
GH - Ghana 8
Totale 110.325
Salva come PNG Salva come JPEG
Città #
Dallas 7.996
Southend 4.837
Singapore 4.784
Ashburn 2.814
San Jose 2.710
Beijing 2.691
Woodbridge 2.675
Chandler 2.320
Ann Arbor 2.295
Houston 2.098
Hong Kong 1.715
Fairfield 1.626
San Mateo 1.470
Moscow 1.304
Falls Church 1.263
Jacksonville 1.101
Seattle 1.084
Dearborn 1.020
Ho Chi Minh City 991
Cambridge 965
Los Angeles 928
Wilmington 886
Ottawa 859
The Dalles 793
Pisa 639
Chicago 618
Hanoi 618
Hefei 542
Boardman 532
Dublin 521
Lauterbourg 513
Stevenage 512
New York 511
Portsmouth 502
Warsaw 490
Dong Ket 483
São Paulo 440
Helsinki 426
Santa Clara 418
Montréal 403
Lawrence 385
Buffalo 335
Beauharnois 315
Brooklyn 311
Milan 278
Council Bluffs 268
Rome 263
Tel Aviv 251
London 249
Munich 247
Orem 235
Salt Lake City 227
Mexico City 197
Montreal 182
Frankfurt am Main 181
Redwood City 175
Florence 174
San Diego 173
Tokyo 164
Old Bridge 158
Stockholm 152
Chennai 150
Istanbul 148
Rio de Janeiro 144
Denver 141
Poplar 141
Amsterdam 134
Da Nang 134
Johannesburg 134
Atlanta 127
Haiphong 118
Phoenix 117
Toronto 113
Fremont 111
Tampa 111
Elk Grove Village 110
Nuremberg 108
Boston 106
Manchester 92
Tashkent 90
San Francisco 79
Ankara 78
Biên Hòa 74
Belo Horizonte 72
Brasília 71
Curitiba 71
Turku 69
Baghdad 68
Washington 68
Norwalk 67
Guayaquil 66
Mumbai 66
Quito 65
Paris 64
Livorno 63
Lucca 63
Dhaka 62
Bologna 60
Central District 60
Lappeenranta 60
Totale 67.988
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.674
Value in Healthcare and the Role of the Patient Voice 1.165
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 689
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 597
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 554
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 482
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 466
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 465
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 443
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 406
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 393
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 382
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 365
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 360
A simple echocardiographic score to rule out cardiac amyloidosis 359
Human pathophysiological adaptations to the space environment 352
Grapevine microRNAs in an in vitro model of cell line: new potential insight on their role in the setting of human health. 349
Functional ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid attenuates post-ischemic myocardial remodeling in rats 342
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 338
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 336
La neuropatia diabetica 335
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 334
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 330
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 330
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 328
A simple echocardiographic score to rule out cardiac amyloidosis 325
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 323
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 322
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 322
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 321
Treating chemoreflex in heart failure: modulation or demolition? 321
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 320
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 319
Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin i 318
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 316
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 314
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 314
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 314
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 312
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 311
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 311
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 309
Tuscany Sangiovese Grape juice imparts cardioprotection by regulating gene expression of Cardioprotective C-Type Natriuretic Peptide. 309
Adrenergic activation in heart failure: blockade or rebalance? 307
[Central apneas and cardiovascular diseases] 302
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 302
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 302
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 301
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 298
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 298
Prediction of the chemoreflex gain by common clinical variables in heart failure 296
Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples 296
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 294
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 293
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 292
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 292
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 292
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 290
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 289
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 289
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 289
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 287
Bioinformatics analysis of the gene profile of coronary endothelial cells treated with Grapevine microRNAs: an in vitro study 287
Ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid as a novel preoperative functional food for suppressing the progression of cardiovascular remodeling in infarcted male rats 285
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 285
Natriuretic peptides expression in a murine model of myocardial infarction after Sangiovese grape juice intake. Focus on CNP and ON putative involvement of plant miRNAs in-vitro and in healthy humans 285
A longitudinal assessment of chronic care pathways in real-life: self-care and outcomes of chronic heart failure patients in Tuscany 284
Acute and persistent effects of a 46-kilometer wilderness trail run at altitude: cardiovascular autonomic modulation and baroreflexes. 284
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 283
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 281
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 281
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 279
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 279
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 279
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 279
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 277
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 277
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 275
Sex-related differences in chronic heart failure 274
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 273
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 273
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 271
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 270
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 270
How to take arms against central apneas in heart failure 268
Screening the health status of people working in a university 267
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 266
Cardiac light-chain deposition disease relapsing in the transplanted heart 265
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 264
Marcatori di rimodellamento e fibrosi cardiaca 264
The evolution of TAVI performance overtime: an overview of systematic reviews 262
Evaluation of analytical performance and qualità specifications of a novel immunoenzymometric assay for cTnI: comparison with cTnI and cTnT immunoassays 262
The metabolic exercise test data combined with Cardiac and Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 262
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 262
Renal denervation in resistant arterial hypertension: Effects on neurohormonal activation and cardiac natriuretic peptides 261
Evaluation of reference change values for a hs-cTnI immunoassay using both plasma samples of healthy subjects and patients and quality control samples 261
Prognostic Value of Indeterminable Anaerobic Threshold in Heart Failure. 260
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 260
Influence of Type of Surgery on the Occurrence of Parasympathetic Reinnervation After Cardiac Transplantation 259
Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible? 259
Totale 33.817
Salva come PNG Salva come JPEG
Categoria #
all - tutte 540.574
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 540.574
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.720 0 0 0 0 0 0 0 0 0 623 744 1.353
2021/20226.927 477 1.282 379 663 153 119 764 1.269 561 670 114 476
2022/20235.337 402 312 276 790 779 826 53 432 917 106 244 200
2023/20243.247 292 112 528 227 210 337 303 190 191 167 168 522
2024/202521.093 192 234 1.198 489 999 1.286 2.826 5.165 1.700 1.412 3.316 2.276
2025/202644.331 2.676 8.082 5.678 6.166 5.331 3.021 5.769 2.122 2.720 2.766 0 0
Totale 111.141